Daniel L. Barber, PhD

Daniel L. Barber, PhD

@danbarberphd.bsky.social

Immunologist. Major focus is on T cell responses to Mycobacterium tuberculosis infection.

2.3K followers280 following19 posts

Daniel L. Barber, PhD reposted

So we blocked IFNγ in Mtb infected macaques and….the animals were fine. Turns out mice overestimate the importance of IFNγ in TB because IFNγ drives iNOS in mice but not macaques or humans. This means we don’t actually know how T cells suppress Mtb. rdcu.be/ff9GB #tuberculosis #immunology

rdcu.beIFNγ blockade in Mycobacterium tuberculosis infected macaques alters the granuloma environment but not bacterial controlNature Communications - Here, the authors show that IFNγ blockade does not impair resistance to Mycobacterium tuberculosis infection in macaques, opposed to what has been observed in mice, due...

Important paper by Björn Corleis. For decades a central tenet of #tuberculosis immunology has that IFNγ-driven iNOS expression in macrophages is the primary mechanism of bacterial control. Turns out this is really only in mice and maybe cattle. It’s not true in most species including humans an NHP.

bioRxiv Immunology@biorxiv-immuno.bsky.social

Species-specific iNOS expression distinguishes epithelial and myeloid IFNγ responses in tuberculosis https://www.biorxiv.org/content/10.64898/2026.01.11.697682v1

We are looking to hire post-docs to work on T cell responses to M. tuberculosis infection using murine and NHP models. If you know T cells and wanna work on the top global infectious killer check us out. BSL3 experience not required. The NIH intramural program in Bethesda MD is an amazing place!

We are looking for post-docs interested in studying T cell responses to M. tuberculosis infection…especially basic T cell immunologists who are interested in learning to work with BSL3 pathogens. The NIH intramural program is an amazing place to train!

What an incredible analysis!!!

Erin McCaffrey, PhD@erin-mccaffrey.bsky.social

Happy to share a preprint from the Angelo lab many years in the making. Read on for a saga of multiplexed imaging, immunometabolism, and TB granulomas with some fun side quests into the realms of geographical information sciences and transcriptomics… (1/20) doi.org/10.1101/2025...

Daniel L. Barber, PhD reposted

Replying to @pauljbaker.bsky.social

More details in this 🧵 from my powerhouse PI @mayerbarber.bsky.social whose foresight and guidance got us to this fantastic manuscript!

Kat Mayer-Barber,PhD@mayerbarber.bsky.social

Best #Nikolaus 🎅! Our paper on how the 🫁 microenvironment can shape #innate immunity against #viruses is out @sciimmunology.bsky.social This was a herculean effort brilliantly led by @pauljbaker.bsky.social who singlehandedly established the model in the lab during the pandemic. 🧪 #Immunosky 1/9

Daniel L. Barber, PhD reposted

Excited to share this paper from my post-doc at @niaidnews.bsky.social out now in Science Immunology! We show that recent or ongoing 🫁 infections or other pulmonary environmental exposures at the time of infection with SARSCoV2 can vastly influence early replication of the virus in mice.

science.orgThe inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replicationRecent or ongoing respiratory inflammation in the lung regulates antiviral immune responses to SARS-CoV-2.

Daniel L. Barber, PhD reposted

Daniel L. Barber, PhD reposted

As community here grows, need for starter packs will rapidly be replaced by need to curate timelines. Enter Bluesky's custom feeds! I have made one for tuberculosis / TB posts, though it may lack specificity. Feel free to pin & use it. Feedback welcome #IDSky #MedSky Link👉 bsky.app/profile/did:...

Daniel L. Barber, PhD reposted

Excited for my first post here to be our new #preprint. 👇🏻check it out below … the recent pulmonary exposure history matters for limiting SARS-CoV-2 viral titers in the 🫁”tweetorial” to follow later

bioRxiv Immunology@biorxiv-immuno.bsky.social

The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication https://www.biorxiv.org/content/10.1101/2024.03.27.586885v1

You are up to date.